2012
Rationale and design of the Prevention of Cardiac Dysfunction During an Adjuvant Breast Cancer Therapy (PRADA) Trial.
Heck, S.L. and Gulati, G. and Ree, A.H. and Schulz-Menger, J. and Gravdehaug, B. and Rosjo, H. and Steine, K. and Bratland, A. and Hoffmann, P. and Geisler, J. and Omland, T.
Cardiology 123
(4): 240-247.
30 November 2012
2003
Rosuvastatin - A highly effective new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor: Review of clinical trial data at 10-40 mg doses in dyslipidemic patients.
Schuster, H.
Cardiology 99
(3): 126-139.
June 2003
1995
Local renin-angiotensin systems in cardiovascular tissues: localization and functional role.
Stock, P. and Liefeld, L. and Paul, M. and Ganten, D.
Cardiology 86
(Suppl.1): 2-8.
1 January 1995
1991
Tissue renin-angiotensin systems and their modulation: the heart as a paradigm for new aspects of converting enzyme inhibition.
Lindpaintner, K. and Ganten, D.
Cardiology 79
(Suppl 1): 32-44.
1 January 1991
This list was generated on Thu Mar 28 02:31:42 2024 CET.